This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (119)

Published on in Vol 6, No 3 (2017): March

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Authors of this article:

Ian Gilron 1 Author Orcid Image ;   Dongsheng Tu 1 Author Orcid Image ;   Ronald Holden 1 Author Orcid Image ;   Tanveer Towheed 1 Author Orcid Image ;   Dan Ziegler 2 Author Orcid Image ;   Louie Wang 1 Author Orcid Image ;   Roumen Milev 1 Author Orcid Image ;   Christopher Gray 3 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics
Ian Gilron 1, MSc, FRCPC, MD;  Dongsheng Tu 1, PhD;  Ronald Holden 1, PhD;  Tanveer Towheed 1, FRCPC, MD;  Dan Ziegler 2, Prof Dr Med;  Louie Wang 1, MSc, FRCPC, MD;  Roumen Milev 1, FRCPC, MD, PhD;  Christopher Gray 3, CCRP

1 Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute , Kingston, ON, CA

2 Heinrich Heine University , Dusseldorf , DE

3 Kingston General Hospital , Kingston, ON, CA

Corresponding Author: